Advus Financial Partners, LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.37M Sell
1,145
-116
-9% -$119K 0.31% 66
2026
Q1
$1.16M Buy
1,261
+128
+11% +$130K 0.29% 67
2025
Q4
$1.22M Sell
1,133
-221
-16% -$211K 0.3% 63
2025
Q3
$1.03M Sell
1,354
-311
-19% -$231K 0.25% 68
2025
Q2
$1.3M Buy
1,665
+20
+1% +$15.5K 0.33% 53
2025
Q1
$1.36M Buy
1,645
+93
+6% +$77.4K 0.38% 47
2024
Q4
$1.2M Buy
1,552
+157
+11% +$130K 0.34% 49
2024
Q3
$1.24M Sell
1,395
-13
-0.9% -$11.7K 0.35% 50
2024
Q2
$1.28M Sell
1,408
-4
-0.3% -$3.2K 0.39% 43
2024
Q1
$1.1M Sell
1,412
-49
-3% -$34.9K 0.34% 46
2023
Q4
$852K Sell
1,461
-40
-3% -$23.3K 0.29% 53
2023
Q3
$806K Buy
1,501
+59
+4% +$30.4K 0.32% 52
2023
Q2
$676K Buy
1,442
+211
+17% +$88.5K 0.26% 58
2023
Q1
$423K Buy
1,231
+62
+5% +$20.9K 0.18% 81
2022
Q4
$428K Buy
1,169
+54
+5% +$19.1K 0.19% 83
2022
Q3
$361K Buy
1,115
+65
+6% +$20.6K 0.19% 80
2022
Q2
$341K Buy
1,050
+84
+9% +$25.2K 0.18% 79
2022
Q1
$277K Buy
+966
New +$249K 0.14% 95
2021
Q3
$225K Buy
+815
New +$201K 0.12% 90

Other funds holding LLY

Advus Financial Partners, LLC's LLY Position: Q2 2026 in Review

Advus Financial Partners, LLC reduced its Eli Lilly (LLY) stake by 9.2% in Q2 2026, selling an estimated $119K and leaving 1,145 shares worth $1.37M. The position accounts for 0.31% of the portfolio, ranked #66.

Advus Financial Partners, LLC first reported a position in LLY in Q3 2021 and has held it in 19 quarters since. 4,613 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Advus Financial Partners, LLC held 1,145 shares of Eli Lilly worth $1.37M as of Q2 2026.
  • Advus Financial Partners, LLC sold 116 Eli Lilly shares in Q2 2026, an estimated $119K.
  • Eli Lilly made up 0.31% of Advus Financial Partners, LLC's portfolio in Q2 2026, its #66 holding.
  • Advus Financial Partners, LLC first reported a position in Eli Lilly in Q3 2021 and has held it in 19 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Advus Financial Partners, LLC's 13F filing for Q2 2026, filed 25 Aug 2026.